PT  - JOURNAL ARTICLE
AU  - Shuman, Jill
ED  - Ullmann, Andrew J.
ED  - Goff, Debra
TI  - Additional Results From SECURE
DP  - 2015 Jul 23
TA  - MD Conference Express
PG  - 8--9
VI  - 15
IP  - 48
4099  - http://mdc.sagepub.com/content/15/48/8.short
4100  - http://mdc.sagepub.com/content/15/48/8.full
AB  - Data from the SECURE trial suggested that isavuconazole was not inferior to voriconazole when treating invasive fungal diseases. Data from 2 subsets of SECURE now show that patients taking isavuconazole are less likely to suffer from treatment-emergent adverse events and that the drug is both safe and effective for obese patients.